Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-23-044257

Director sold 265 shares at $42.33 ($11,217)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bhanji Muna Director 2023-07-31 Sale 10b5-1 −265 $42.33 $11,217 12,261 D
Open-market sales · 265 sh · avg $42.33 · $11,217
Loading xslF345X05/doc4.xml…